A091401 Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Patients With Metastatic or Unresectable Sarcoma
Ontology highlight
ABSTRACT: A091401 Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Patients With Metastatic or Unresectable Sarcoma
PROVIDER: PRJNA1164329 | ENA |
REPOSITORIES: ENA
ACCESS DATA